BILL ANALYSIS                                                                                                                                                                                                    Ó




           ----------------------------------------------------------------- 
          |SENATE RULES COMMITTEE            |                        SB 613|
          |Office of Senate Floor Analyses   |                              |
          |(916) 651-1520    Fax: (916)      |                              |
          |327-4478                          |                              |
           ----------------------------------------------------------------- 


                                UNFINISHED BUSINESS 


          Bill No:  SB 613
          Author:   Allen (D)
          Amended:  7/6/15  
          Vote:     21  

           SENATE HEALTH COMMITTEE:  9-0, 4/29/15
           AYES:  Hernandez, Nguyen, Hall, Mitchell, Monning, Nielsen,  
            Pan, Roth, Wolk

           SENATE APPROPRIATIONS COMMITTEE:  7-0, 5/28/15
           AYES:  Lara, Bates, Beall, Hill, Leyva, Mendoza, Nielsen

           SENATE FLOOR:  40-0, 6/1/15
           AYES:  Allen, Anderson, Bates, Beall, Berryhill, Block,  
            Cannella, De León, Fuller, Gaines, Galgiani, Glazer, Hall,  
            Hancock, Hernandez, Hertzberg, Hill, Hueso, Huff, Jackson,  
            Lara, Leno, Leyva, Liu, McGuire, Mendoza, Mitchell, Monning,  
            Moorlach, Morrell, Nguyen, Nielsen, Pan, Pavley, Roth, Runner,  
            Stone, Vidak, Wieckowski, Wolk

           ASSEMBLY FLOOR:  80-0, 9/3/15 - See last page for vote

           SUBJECT:   State Department of Public Health: dementia  
                     guidelines: workgroup


          SOURCE:   Alzheimers Association 


          DIGEST:   This bill requires the Department of Public Health  
          (DPH) to convene a workgroup to update the 2008 Guidelines for  
          Alzheimer's Disease Management in California to address changes  
          in the health care system, and requires DPH to submit a report  
          of the updates and recommendations from the working group to the  
          Legislature on or before March 1, 2017.








                                                                     SB 613  
                                                                    Page  2




          Assembly Amendments make a clarifying change.

          ANALYSIS:
               
          Existing law:

          1)Requires the California Health and Human Services Agency to  
            establish an Alzheimer's Disease and Related Disorders  
            Advisory Committee consisting of 14 members, and requires the  
            Committee to:

             a)   Provide ongoing advice and assistance to the  
               Administration and the Legislature as to the program needs  
               and priorities of the target population.

             b)   Provide planning support to the Administration and the  
               Legislature by updating recommendations of the 1987  
               California Alzheimer's Disease Task Force Report and  
               regularly reviewing and updating recommendations as needed.

          1)Requires DPH to provide public and professional education on  
            Alzheimer's disease to educate consumers, caregivers, and  
            health care providers, and to increase public awareness.

          This bill:

          1)Requires DPH to convene a workgroup to update the 2008  
            Guidelines for Alzheimer's Disease Management in California to  
            address changes in the health care system, including, but not  
            limited to, changes in the federal Patient Protection and  
            Affordable Care Act, Medicaid, and Medicare. 

          2)Permits the workgroups to draw on evidence-based,  
            peer-reviewed research and lessons learned from demonstration  
            and pilot projects in updating the Guidelines.

          3)Requires the workgroup to consist of members determined by the  
            DPH, and permits the workgroup to include multidisciplinary  
            experts in Alzheimer's disease detection, diagnosis,  
            treatment, and support.









                                                                     SB 613  
                                                                    Page  3



          4)Requires DPH to submit a report of the updates and  
            recommendations from the working group to the Legislature on  
            or before March 1, 2017.

          5)Sunsets on January 1, 2018.

          Comments

          1)Author's statement.  According to the author, "Alzheimer's  
            disease is a public health crisis in California, but unlike  
            other public health concerns there is no known cause, cure or  
            prevention to reduce the impact on individuals, families,  
            communities and our state's public programs such as Medi-Cal  
            and IHSS. The author states we've seen a 42 increase in just  
            the last decade. Experts agree that managing the course of  
            Alzheimer's disease after a diagnosis is the best public  
            health strategy we have available today. This bill proposes a  
            statewide working group under the leadership of DPH, drawing  
            on the existing resources and expertise of our state's 10  
            university-affiliated Alzheimer's Disease Centers.  The  
            state's own experts will update the physician Guideline for  
            Alzheimer's Disease Management to systematically improve  
            quality of care, better manage complex patient populations,  
            and lower public costs associated with Medi-Cal-funded  
            hospital stays and nursing home placements. The author  
            concludes that when someone in California learns they have  
            Alzheimer's, there should be evidence-based, up to date,  
            guidelines for physicians to follow to ensure the patients  
            receive the care and support they need."

          2)Alzheimer's disease.  According to the federal National  
            Institute on Aging, Alzheimer's disease is an irreversible,  
            progressive brain disease that slowly destroys memory and  
            thinking skills, and eventually even the ability to carry out  
            the simplest tasks. In most people with Alzheimer's, symptoms  
            first appear after age 65. Plaques and tangles in the brain  
            are two of the main features of Alzheimer's disease. The third  
            is the loss of connections between nerve cells (neurons) in  
            the brain. Although treatment can help manage symptoms in some  
            people, currently there is no cure for this disease. Estimates  
            vary, but experts suggest that as many as five million  
            Americans age 65 and older may have Alzheimer's disease. 








                                                                     SB 613  
                                                                    Page  4




          Alzheimer's disease is the most common cause of dementia among  
            older people. Dementia is the loss of cognitive  
            functioning-thinking, remembering, and reasoning-and  
            behavioral abilities, to such an extent that it interferes  
            with a person's daily life and activities. Dementia ranges in  
            severity from the mildest stage, when it is just beginning to  
            affect a person's functioning, to the most severe stage, when  
            the person must depend completely on others for basic  
            activities of daily living.

          3)2008 Guidelines for Alzheimer's Disease Management.  The  
            "Guidelines for Alzheimer's Disease Management - California  
            Workgroup on Guidelines for Alzheimer's Disease Management  
            Final Report 2008" was published to update and expand previous  
            Guidelines issued in 2002 and 1998. The 1998 effort was paid  
            for through a Health Resources and Services Administration  
            grant. The Guidelines were based upon work begun by the Ad Hoc  
            Standards of Care Committee of the Alzheimer's Disease  
            Diagnostic and Treatment Centers of California and were  
            supported in part by the State of California, Department of  
            Health Services, and the Alzheimer's Association, California.  
            Southland Chapter. The California Council of the Alzheimer's  
            Association sponsored the Alzheimer's Disease Education  
            Initiative (ADEI) and secured a one-time $2.4 million budget  
            augmentation in FY 2000-01 to launch a public education  
            campaign centered on the Guidelines for Alzheimer's Disease  
            Management. The funds from the ADEI were used to pay for the  
            2002 update.  

            The 2008 Guidelines state that most older adults, including  
            those with Alzheimer's disease, receive their medical care  
            from Primary Care Practitioners (PCPs) who may lack the  
            information and other resources they need to treat this  
            growing and demanding population. The 2008 Guidelines was  
            intended to provide assistance to PCPs in offering  
            comprehensive care to patients with Alzheimer's disease and  
            those who care for them over the course of their illness. The  
            Guidelines' recommendations are organized by major care issues  
            (assessment, treatment, patient and family education and  
            support, and legal considerations). Each section of the  
            Guidelines deals with one of the four care issues and provides  








                                                                     SB 613  
                                                                    Page  5



            an overview of the issue, followed by the care recommendations  
            and a review of the literature supporting them. The language  
            used throughout the report reflects the strength of the  
            supporting evidence, either "strong" (e.g., randomized  
            clinical trial) or "moderate." In some instances,  
            recommendations that are not evidence-based are nevertheless  
            supported by expert opinion and workgroup consensus, and are  
            labeled as such.

          FISCAL EFFECT:   Appropriation:    No          Fiscal  
          Com.:YesLocal:   No


          According to the Assembly Appropriations Committee, a negligible  
          fiscal impact, including a total estimated cost to update the  
          Guidelines of $120,000.


          SUPPORT:   (Verified9/3/15)


          Alzheimer's Association (source)
          American Federation of State, County and Municipal Employees,  
                    AFL-CIO
          California Commission on Aging
          Leading Age California


          OPPOSITION:   (Verified9/3/15)


          Department of Finance


          ARGUMENTS IN SUPPORT:     This bill is sponsored by the  
          Alzheimer's Association to update California's physician  
          Guidelines for Alzheimer's Disease Management to improve quality  
          of care and support for individuals diagnosed with dementia,  
          manage complex, costly populations in the state's health care  
          delivery system, and reduce individual, family and government  
          health care costs. The Alzheimer's' Association states this bill  
          draws on the existing resources and expertise within DPH's 10  








                                                                     SB 613  
                                                                    Page  6



          university-affiliated Alzheimer's Disease Centers to review and  
          analyze evidence in support of a state-of-the-art guideline for  
          Alzheimer's disease management. The Alzheimer's Association  
          states that Medi-Cal beneficiaries with a diagnosis of  
          Alzheimer's disease have 19 times higher costs than those  
          without a cognitive impairment. Likewise, patients with dementia  
          use hospitals and nursing facilities at more than triple the  
          rate without Alzheimer's. The Alzheimer's Association concludes  
          that the development of a physician Guidelines for Alzheimer's  
          Disease Management advances public policy for patients,  
          physicians and government payors.

          ARGUMENTS IN OPPOSITION:The Department of Finance writes in  
          opposition that this bill because it is unnecessary, as DPH is  
          already in the process of updating the 2008 Guidelines. 

           ASSEMBLY FLOOR:  80-0, 9/3/15
           AYES: Achadjian, Alejo, Travis Allen, Baker, Bigelow, Bloom,  
            Bonilla, Bonta, Brough, Brown, Burke, Calderon, Campos, Chang,  
            Chau, Chávez, Chiu, Chu, Cooley, Cooper, Dababneh, Dahle,  
            Daly, Dodd, Eggman, Frazier, Beth Gaines, Gallagher, Cristina  
            Garcia, Eduardo Garcia, Gatto, Gipson, Gomez, Gonzalez,  
            Gordon, Gray, Grove, Hadley, Harper, Roger Hernández, Holden,  
            Irwin, Jones, Jones-Sawyer, Kim, Lackey, Levine, Linder,  
            Lopez, Low, Maienschein, Mathis, Mayes, McCarty, Medina,  
            Melendez, Mullin, Nazarian, Obernolte, O'Donnell, Olsen,  
            Patterson, Perea, Quirk, Rendon, Ridley-Thomas, Rodriguez,  
            Salas, Santiago, Steinorth, Mark Stone, Thurmond, Ting,  
            Wagner, Waldron, Weber, Wilk, Williams, Wood, Atkins

          Prepared by: Scott Bain / HEALTH / 
          9/3/15 19:04:54


                                   ****  END  ****